Endometrioid adenocarcinoma arising in endometriosis foci six years after estrogen replacement therapy: a case report

Case report OA: green CC0 ⤵ 7 in-corpus citations
🔓 Open OA copy View on OpenAlex View on PubMed
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-08 ⓘ

This case report describes a 53-year-old woman who developed endometrioid adenocarcinoma in endometriosis foci six years after hysterectomy, oophorectomy, and estrogen-only hormone replacement therapy.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

We present a case of a 53-year-old woman who developed an endometrioid adenocarcinoma six years after total abdominal hysterectomy (TAH) and bilateral salpingo-oophorectomy (BSO), who was on estrogenic-only hormone replacement therapy (HRT).

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Carcinoma, Endometrioid Endometriosis Vaginal Neoplasms Antineoplastic Combined Chemotherapy Protocols Antineoplastic Combined Chemotherapy Protocols Antineoplastic Combined Chemotherapy Protocols Carcinoma, Endometrioid Carcinoma, Endometrioid Carcinoma, Endometrioid Carcinoma, Endometrioid Carcinoma, Endometrioid Cisplatin Cisplatin Cisplatin Diagnosis, Differential Diagnosis, Differential Doxorubicin Doxorubicin Doxorubicin Endometriosis

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

Cited by (7)

SciLite annotations

chemicals 1
estrogen

Source provenance

europepmc
last seen: 2026-10-16T06:09:50.462052+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:02:29.018211+00:00
scilite
last seen: 2026-05-18T04:25:29.313245+00:00
License: CC0 · commercial use OK